Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Large Volume Parenteral (LVP) market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Large Volume Parenteral (LVP) market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Large Volume Parenteral (LVP) market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Large Volume Parenteral (LVP) products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Large Volume Parenteral (LVP) products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Large Volume Parenteral (LVP) market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Large Volume Parenteral (LVP) development has been the leading industry trend of Large Volume Parenteral (LVP) market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Large Volume Parenteral (LVP) Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Fluid Balance Injections,Therapeutic Injections,Nutritious Injections, Other |
| By Application Outlook |
Hospitals,Medical Centers,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Ostuka Pharmaceutical,Teva Pharmaceutical Industries,Kelun Pharma,Cook Pharmica,Patheon,BAG Healthcare,Southwest Pharmaceutical,Cook Pharmica,Beximco Pharma,Baxter Healthcare Corporation |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Ostuka Pharmaceutical
- Teva Pharmaceutical Industries
- Kelun Pharma
- Cook Pharmica
- Patheon
- BAG Healthcare
- Southwest Pharmaceutical
- Cook Pharmica
- Beximco Pharma
- Baxter Healthcare Corporation
Large Volume Parenteral (LVP) Market, By Type
- Fluid Balance Injections
- Therapeutic Injections
- Nutritious Injections
- Other
Large Volume Parenteral (LVP) Market, By Application
- Hospitals
- Medical Centers
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Large Volume Parenteral (LVP) Market Overview
1.1 Large Volume Parenteral (LVP) Product Overview
1.2 Large Volume Parenteral (LVP) Market Segment by Type
1.2.1 Fluid Balance Injections
1.2.2 Therapeutic Injections
1.2.3 Nutritious Injections
1.3 Global Large Volume Parenteral (LVP) Market Size by Type
1.3.1 Global Large Volume Parenteral (LVP) Sales and Growth by Type
1.3.2 Global Large Volume Parenteral (LVP) Sales and Market Share by Type (2017-2020)
1.3.3 Global Large Volume Parenteral (LVP) Revenue and Market Share by Type (2017-2020)
1.3.4 Global Large Volume Parenteral (LVP) Price by Type (2017-2020)
2 Global Large Volume Parenteral (LVP) Market Competition by Company
2.1 Global Large Volume Parenteral (LVP) Sales and Market Share by Company (2017-2020)
2.2 Global Large Volume Parenteral (LVP) Revenue and Share by Company (2017-2020)
2.3 Global Large Volume Parenteral (LVP) Price by Company (2017-2020)
2.4 Global Top Players Large Volume Parenteral (LVP) Manufacturing Base Distribution, Sales Area, Product Types
2.5 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.5.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.5.2 Global Large Volume Parenteral (LVP) Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Large Volume Parenteral (LVP) Company Profiles and Sales Data
3.1 Ostuka Pharmaceutical
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.1.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Teva Pharmaceutical Industries
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.2.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Kelun Pharma
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.3.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Cook Pharmica
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.4.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Patheon
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.5.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 BAG Healthcare
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.6.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Southwest Pharmaceutical
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.7.3 Southwest Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Cook Pharmica
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.8.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Beximco Pharma
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.9.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 Baxter Healthcare Corporation
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
3.10.3 Baxter Healthcare Corporation Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
4 Large Volume Parenteral (LVP) Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Large Volume Parenteral (LVP) Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Large Volume Parenteral (LVP) Sales and Revenue by Regions
4.2.1 Global Large Volume Parenteral (LVP) Sales and Market Share by Regions (2017-2020)
4.2.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Large Volume Parenteral (LVP) Application/End Users
5.1 Large Volume Parenteral (LVP) Segment by Application
5.1.1 Hospitals
5.1.2 Medical Centers
5.1.3 Others
5.2 Global Large Volume Parenteral (LVP) Product Segment by Application
5.2.1 Global Large Volume Parenteral (LVP) Sales by Application
5.2.2 Global Large Volume Parenteral (LVP) Sales and Market Share by Application (2017-2020)
6 Global Large Volume Parenteral (LVP) Market Forecast
6.1 Global Large Volume Parenteral (LVP) Sales, Revenue Forecast (2021-2027)
6.1.1 Global Large Volume Parenteral (LVP) Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Large Volume Parenteral (LVP) Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Large Volume Parenteral (LVP) Forecast by Regions
6.2.1 North America Large Volume Parenteral (LVP) Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Large Volume Parenteral (LVP) Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Large Volume Parenteral (LVP) Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Large Volume Parenteral (LVP) Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Large Volume Parenteral (LVP) Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Large Volume Parenteral (LVP) Forecast by Type
6.3.1 Global Large Volume Parenteral (LVP) Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Fluid Balance Injections Gowth Forecast
6.3.3 Therapeutic Injections Gowth Forecast
6.4 Large Volume Parenteral (LVP) Forecast by Application
6.4.1 Global Large Volume Parenteral (LVP) Sales Forecast by Application (2021-2027)
6.4.2 Global Large Volume Parenteral (LVP) Forecast in Hospitals
6.4.3 Global Large Volume Parenteral (LVP) Forecast in Medical Centers
7 Large Volume Parenteral (LVP) Upstream Raw Materials
7.1 Large Volume Parenteral (LVP) Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Large Volume Parenteral (LVP) Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
